NK314, a Topoisomerase II Inhibitor That Specifically Targets the α Isoform
2008 · Journal of Biological Chemistry · 103 citations
https://doi.org/10.1074/jbc.m803936200
E
Eriko Toyoda
Tokai University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
695
Citations
13
h-index
17
i10-index
Eriko Toyoda is an academic researcher from Tokai University. The author has contributed to research in topics: Osteoarthritis Treatment and Mechanisms & Cancer therapeutics and mechanisms & Knee injuries and reconstruction techniques. The author has an h-index of 13, co-authored 45 publications.
ORCID: 0000-0002-8789-2501Papers by this author
worksPolydactyly-derived allogeneic chondrocyte cell-sheet transplantation with high tibial osteotomy as regenerative therapy for knee osteoarthritis
2022 · npj Regenerative Medicine · 25 citations
https://doi.org/10.1038/s41536-022-00272-1
Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue
2018 · Regenerative Therapy · 19 citations
https://doi.org/10.1016/j.reth.2018.10.005
Cartilage repair and inhibition of the progression of cartilage degeneration after transplantation of allogeneic chondrocyte sheets in a nontraumatic early arthritis model
2018 · Regenerative Therapy · 13 citations
https://doi.org/10.1016/j.reth.2018.07.003
A novel chondrocyte sheet fabrication using human-induced pluripotent stem cell-derived expandable limb-bud mesenchymal cells
2023 · Stem Cell Research & Therapy · 9 citations
https://doi.org/10.1186/s13287-023-03252-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat